Tag

Contract Research & Manufacturing

2 articles

Anthem Biosciences Reports Strong FY26 Results with 15% Revenue Growth

Anthem Biosciences reported 15.2% revenue growth to ₹21,243 million and 31.1% PAT growth to ₹5,918 million in FY26, demonstrating strong financial performance. The company successfully completed its ₹

Anthem Biosciences FY26 Voluntary BRSR Report

Anthem Biosciences voluntarily filed its Business Responsibility and Sustainability Report for FY 2025-26, ahead of the SEBI-mandated timeline. The company reported 85% export revenue contribution and